Ujwala Mahatme

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Ujwala Mahatme
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ujwala Mahatme:

Company Role Class Num Shares Value Price $ Report Date Ownership
Summit Therapeutics Inc. Director Stock Option (right to buy) 87,575 $115,599 $1.32 02 Jan 2024 Direct

Insider Reports Filed by Ujwala Mahatme

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SMMT Summit Therapeutics Inc. 02 Jan 2024 2 +$69,399 4 Director 04 Jan 2024, 16:22
SMMT Summit Therapeutics Inc. 03 Jan 2023 2 +$67,635 4 Director 05 Jan 2023, 15:14
SMMT Summit Therapeutics Inc. 03 Jan 2022 2 +$54,095 4 Director 05 Jan 2022, 15:05